Characterization of prostate cancers potentially amenable to tyrosine kinase inhibitors of platelet derived growth factor receptor

被引：0
|
作者：
Fecko, A [1 ]
Shen, RL [1 ]
Chinnaiyan, AM [1 ]
Rubin, MA [1 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
来源：
LABORATORY INVESTIGATION | 2003年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
675
引用
收藏
页码：149A / 149A
页数：1
相关论文
共 50 条
  • [1] Characterization of prostate cancers potentially amenable to tyrosine kinase inhibitors of platelet derived growth factor receptor
    Fecko, A
    Shen, RL
    Chinnaiyan, AM
    Rubin, MA
    MODERN PATHOLOGY, 2003, 16 (01) : 149A - 149A
  • [2] Inhibitors of the platelet-derived growth factor receptor tyrosine kinase
    Bilder, GE
    Rojas, CJ
    CARDIOVASCULAR DRUG REVIEWS, 1996, 14 (04): : 380 - 399
  • [3] In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors
    Sawutz, DG
    Bode, DC
    Briggs, GM
    Reid, JR
    Canniff, P
    Caldwell, L
    Faltynek, CR
    Miller, D
    Dunn, JA
    deGaravilla, L
    Guiles, JW
    Weigelt, C
    Michne, W
    Treasurywala, AM
    Silver, PJ
    BIOCHEMICAL PHARMACOLOGY, 1996, 51 (12) : 1631 - 1638
  • [4] Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors
    Hofer, MD
    Fecko, A
    Shen, RL
    Setlur, SR
    Pienta, KG
    Tomlins, SA
    Chinnaiyan, AM
    Rubin, MA
    NEOPLASIA, 2004, 6 (05): : 503 - 512
  • [5] Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
    Hofer, MD
    Fecko, A
    Shen, R
    Setlur, SR
    Pienta, KG
    Tomlins, S
    Chinnaiyan, AM
    Rubin, MA
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6123S - 6123S
  • [6] Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature
    Dai, Yujia
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (07) : 885 - 907
  • [7] A potent inhibitor of platelet-derived growth factor receptor tyrosine kinase
    Min, DS
    Lee, YH
    Kang, LW
    Byoun, CH
    Chang, JS
    Ryn, SH
    Suh, PG
    MOLECULES AND CELLS, 1996, 6 (04) : 463 - 468
  • [8] Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats
    Rice, AB
    Moomaw, CR
    Morgan, DL
    Bonner, JC
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (01): : 213 - 221
  • [9] Epidermal growth factor receptor tyrosine kinase inhibitors
    Wakeling, AE
    CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (04) : 382 - 387
  • [10] Epidermal growth factor receptor tyrosine kinase inhibitors
    M Ranson
    British Journal of Cancer, 2004, 90 : 2250 - 2255
12345